Halozyme Therapeutics, Inc. (NASDAQ:HALO)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Recs

0
Player Avatar JohanHansen (75.47) Submitted: 4/20/2010 11:17:57 PM : Outperform Start Price: $8.50 HALO Score: -11.45

Myst 3Cmb1 A xxx

Featured Broker Partners


Advertisement